These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 24465642)
1. Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling. Potter CS; Wang Z; Silva KA; Kennedy VE; Stearns TM; Burzenski L; Shultz LD; Hogenesch H; Sundberg JP PLoS One; 2014; 9(1):e85666. PubMed ID: 24465642 [TBL] [Abstract][Full Text] [Related]
2. Integrin beta 1 inhibition alleviates the chronic hyperproliferative dermatitis phenotype of SHARPIN-deficient mice. Peuhu E; Salomaa SI; De Franceschi N; Potter CS; Sundberg JP; Pouwels J PLoS One; 2017; 12(10):e0186628. PubMed ID: 29040328 [TBL] [Abstract][Full Text] [Related]
3. Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice. Renninger ML; Seymour RE; Whiteley LO; Sundberg JP; Hogenesch H Exp Dermatol; 2010 Mar; 19(3):252-8. PubMed ID: 19650867 [TBL] [Abstract][Full Text] [Related]
14. Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death. Ang RL; Chan M; Legarda D; Sundberg JP; Sun SC; Gillespie VL; Chun N; Heeger PS; Xiong H; Lira SA; Ting AT Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34887354 [TBL] [Abstract][Full Text] [Related]
15. Accumulation and activation of epidermal γδ T cells in a mouse model of chronic dermatitis is not required for the inflammatory phenotype. Sulcova J; Maddaluno L; Meyer M; Werner S Eur J Immunol; 2015 Sep; 45(9):2517-28. PubMed ID: 26081170 [TBL] [Abstract][Full Text] [Related]
16. Sharpin Controls Osteogenic Differentiation of Mesenchymal Bone Marrow Cells. Jeschke A; Catala-Lehnen P; Sieber S; Bickert T; Schweizer M; Koehne T; Wintges K; Marshall RP; Mautner A; Duchstein L; Otto B; Horst AK; Amling M; Kreienkamp HJ; Schinke T J Immunol; 2015 Oct; 195(8):3675-84. PubMed ID: 26363054 [TBL] [Abstract][Full Text] [Related]
17. SHARPIN is a key regulator of immune and inflammatory responses. Wang Z; Potter CS; Sundberg JP; Hogenesch H J Cell Mol Med; 2012 Oct; 16(10):2271-9. PubMed ID: 22452937 [TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in the skin of SHARPIN-deficient mice with chronic proliferative dermatitis. HogenEsch H; Sola M; Stearns TM; Silva KA; Kennedy VE; Sundberg JP Exp Mol Pathol; 2016 Dec; 101(3):303-307. PubMed ID: 27794420 [TBL] [Abstract][Full Text] [Related]
19. Expression of chitinase-like proteins in the skin of chronic proliferative dermatitis (cpdm/cpdm) mice. HogenEsch H; Dunham A; Seymour R; Renninger M; Sundberg JP Exp Dermatol; 2006 Oct; 15(10):808-14. PubMed ID: 16984263 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12. HogenEsch H; Torregrosa SE; Boggess D; Sundberg BA; Carroll J; Sundberg JP Eur J Immunol; 2001 Mar; 31(3):734-42. PubMed ID: 11241277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]